Cyberknife Radiosurgery and Quality of Life

Stanford University15 enrolled

Overview

The purpose of this study is to look at pain control and QOL improvement after treatment with CK Radiosurgery for spinal metastases.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Bone Cancer Central Nervous System Cancer

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients with a spinal metastasis who will be treated with Cyberknife radiosurgery. * There are no age or gender restrictions. * There are no life expectancy restrictions. * Karnofsky Performance Status greater than 40. * Negative pregnancy test or clinically assessed as not pregnant. * Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: * Patients with benign tumors will not be included (neurofibromas, schwannomas, etc.) * Other investigational medications or treatments will be noted, but will not preclude inclusion. * Pregnant or nursing patients will be not be included in the study due to radiation exposure.

Locations (1)

Stanford University School of Medicine

Stanford, California, United States

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.